Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — taking two 0.25mg Wegovy doses in a single week is not safe and not how the medicine is licensed. Wegovy is prescribed as one injection weekly, at the dose your prescriber has set. The 0.25mg starting dose is deliberately low; doubling it does not speed up weight loss, but it does raise your risk of side effects. This is a prescription-only medicine, and every dose adjustment has to go through your prescriber, not your own maths. If you have questions about whether your current dose is right for you, that is exactly the conversation to have with the clinician who prescribed it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who search this question are not trying to cut corners. They are frustrated. Progress on the starting dose feels slow, or they have missed a week and are wondering whether two injections back-to-back would help them catch up. Those are understandable instincts. The trouble is that Wegovy's dosing schedule is built around your body's tolerance, not simply around how much semaglutide a given weight needs. Altering the schedule yourself introduces risks that your prescriber is specifically there to manage.
The NHS medicines page for semaglutide is clear that you should use Wegovy exactly as directed and take each injection on the same day each week. If you miss a dose, the guidance is to inject as soon as you remember, provided your next scheduled dose is still more than five days away. If it is closer than that, you skip the missed dose entirely and continue on your normal day. Our page on whether you can take two doses of Wegovy explains in full why two injections close together is not a recommended catch-up strategy under any circumstance.
It is worth spending one minute before each injection checking the date of your last injection in your notes app or on the pen's own label. That small habit removes a lot of the confusion that leads people here.
Semaglutide is a GLP-1 receptor agonist. At 0.25mg, it is not yet delivering the appetite-reducing effect that makes Wegovy effective for weight management, that comes as the dose is titrated upward over several months, typically moving through 0.5mg, 1mg and 1.7mg before reaching the standard 2.4mg maintenance dose, with a minimum of roughly four weeks at each level. The full Wegovy dosing schedule explains the progression in practical terms.
The reason the titration is slow is physiological. Semaglutide slows how quickly your stomach empties, which is part of how it reduces hunger. Moving too quickly through doses, or taking more than prescribed at any single point, overloads that mechanism and produces nausea, vomiting and diarrhoea that can be severe enough to stop treatment altogether. Doubling your 0.25mg dose to 0.5mg in a single week (which is effectively what two injections would do) bypasses the graduated adjustment your prescriber has planned.
There is no clinical evidence that accelerating the titration by taking two starter doses produces faster weight loss. The STEP 1 trial, which produced the results underpinning Wegovy's licence, was conducted on the standard titration schedule across 68 weeks. Those are the conditions under which the medicine's safety and effectiveness were established.
If you feel the 0.25mg dose is not working, or you have missed an injection and are unsure how to proceed, the right move is to contact whoever prescribed it. That is not a bureaucratic hurdle, it is the point. A prescriber can look at your full picture, assess whether a dose increase is appropriate, and advise on the safest way to handle a missed week. You can also read the practical guide to taking Wegovy doses for general handling advice, though any personalised timing question belongs with your clinician.
On cost, some people consider doubling a dose because they want to use up a pen that has doses remaining. The Wegovy pricing page gives honest context on what private treatment typically costs month by month, and if you are moving through the schedule and wondering what the next tier involves, our guide to the 4.8mg Wegovy dose covers that stage in detail. It is always cheaper, in the long run, to use the medicine as prescribed rather than risk a side-effect episode that disrupts treatment entirely.
If you are looking at Wegovy for the first time and wondering how the starting process works in practice, the guide to the first Wegovy injection covers what to expect from the 0.25mg stage. And if you are curious about how Wegovy compares to other treatment options, the weight-loss treatment overview sets out the full landscape clearly.
If you have already taken two doses close together and are experiencing symptoms, this matters. Gastrointestinal effects like nausea and vomiting are the most likely outcome; stay hydrated and contact your prescriber or GP. Seek urgent medical attention for severe, persistent stomach pain that radiates to the back, with or without vomiting, as this can be a sign of pancreatitis. The MHRA highlighted acute pancreatitis as a known, though infrequent, serious risk with GLP-1 medicines in a January 2026 safety update, it is rare, but it is not something to wait out at home.
You can report any suspected side effects to the MHRA via the Yellow Card reporting scheme. For questions about your own treatment, your prescriber is the first call. If you are not currently on Wegovy and are considering whether it might suit you, checking your eligibility through a free consultation is the right starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.